Doxorubicin hyaluronic acid complex
Alternative Names: Doxorubicin hyaluronan acid complex; HA-doxorubicin; Hyaluronan doxorubicin complex; Hyaluronic acid + doxorubicin; Hyaluronic acid doxorubicin complex; HyDOXLatest Information Update: 14 Jan 2022
At a glance
- Originator Monash University
- Class Anthracyclines; Antineoplastics; Cytostatic antibiotics; Doxorubicins; Small molecules
- Mechanism of Action DNA intercalators; Type II DNA topoisomerase inhibitors
-
Orphan Drug Status
Orphan designation is assigned by a regulatory body to encourage companies to develop drugs for rare diseases.
- New Molecular Entity No
Highest Development Phases
- Suspended Cancer
Most Recent Events
- 07 Mar 2013 Suspended - Phase-I/II for Cancer (metastatic disease, treatment-resistant, late-stage disease) in Australia (IV)
- 14 Aug 2003 Phase-I/IIa clinical trials in Cancer (metastatic disease, treatment-resistant, late-stage disease) in Australia (IV)